Shuttle Pharmaceuticals Holdings Long Term Debt

Shuttle Pharmaceuticals Holdings posts a long-term debt of $130K as of March 2026. That compares with $220K in the prior-year period — down 39.1% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Shuttle Pharmaceuticals Holdings's long-term debt was $220K. The latest reading is $130K — a 39.1% year-over-year decrease (period ending March 2026). Use the history and growth charts on this page for a longer lookback.

Long-Term Debt is one piece of Shuttle Pharmaceuticals Holdings's financial statement story. At $130K, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for SHPH's long-term debt usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Shuttle Pharmaceuticals Holdings's other metric pages and overview cover the third.